|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Viracta Therapeutics (NASDAQ: VIRX) through any online brokerage.
The latest price target for Viracta Therapeutics (NASDAQ: VIRX) was reported by Evercore ISI Group on 2021-03-25. The analyst firm set a price target for 45.00 expecting VIRX to rise to within 12 months (a possible 471.07% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Viracta Therapeutics (NASDAQ: VIRX) is $7.88 last updated Today at 8:00:02 PM.
There are no upcoming dividends for Viracta Therapeutics.
There is no upcoming split for Viracta Therapeutics.